BlackRock
CALT

BlackRock’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

BlackRock’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,191
Closed -$29K – 5199
2020
Q3 		$29K Buy
+1,191
New +$27.8K ﹤0.01% 4670

Other funds holding CALT

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BlackRock's CALT Position: Q4 2020 in Review

BlackRock sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q4 2020, closing a stake of 1,191 shares — an estimated $29K sold.

BlackRock first reported a position in CALT in Q3 2020 and held it in 1 quarter. The position peaked at $29K in Q3 2020. 11 funds tracked by Wall St. Rank hold CALT as of Q4 2020.

  • BlackRock reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • BlackRock sold 1,191 Calliditas Therapeutics AB American Depositary Shares shares in Q4 2020, an estimated $29K.
  • BlackRock first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q3 2020 and held it in 1 quarter.
  • BlackRock's Calliditas Therapeutics AB American Depositary Shares position peaked at $29K in Q3 2020.
  • 11 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q4 2020.

Based on BlackRock's 13F filing for Q4 2020, filed 5 Feb 2021.